Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 19/20 | 0.56 |
| ▸ | RCOR1 | Q9UKL0 | 8/20 | 0.56 |
| ▸ | MAOA | P21397 | 7/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 5/20 | 0.49 |
| ▸ | KDM1B | Q8NB78 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24890734 | 1.00 | KDM1A (0.56) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890722 | 0.94 | KDM1A (0.53) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890529 | 0.92 | KDM1A (0.55) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890655 | 0.92 | KDM1A (0.55) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890538 | 0.92 | KDM1A (0.55) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890762 | 0.92 | KDM1A (0.55) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890749 | 0.92 | KDM1A (0.55) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890731 | 0.88 | KDM1A (0.57) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890682 | 0.88 | KDM1A (0.57) | KDM1ARCOR1MAOAHDAC1HDAC2 | |
| SCHEMBL24890848 | 0.85 | KDM1A (0.77) | KDM1ARCOR1MAOAHDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023284651-A1 | N-(2-AMINOPHENYL)BENZAMIDE COMPOUND AND APPLICATION THEREOF | 南京明德新药研发有限公司 | 2023-01-19 | — | — | WO | disclosed |